Rofecoxib is a nonsteroidal anti-inflammatory drug that is reported to act by selectively inhibiting cyclooxygenase-2. A review and analysis of reports sent to the Spontaneous Reporting System of the Food and Drug Administration, Rockville, Md, suggest that aseptic meningitis is associated with rofecoxib use. To our knowledge, there have been no published reports of aseptic meningitis occurring in association with rofecoxib use to date. We report 5 serious cases of aseptic meningitis associated with rofecoxib use.
Bonnel RA, Villalba ML, Karwoski CB, Beitz J. Aseptic Meningitis Associated With Rofecoxib. Arch Intern Med. 2002;162(6):713–715. doi:10.1001/archinte.162.6.713
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.